Do you have the same question? Follow this Question
Feb 20, 2025 - 12:40 PM
We’ve provided several answers to questions related to Olumiant (Baricitinib) , see some other helpful Q&A related to this product.
Question: What are the risks associated with the product?
Answer: Risks include serious infections, mortality, malignancy, major adverse cardiovascular events (MACE), and thrombosis. Understanding these risks is crucial for informed decision-making and enables proactive monitoring to minimize potential adverse outcomes.
Question: What is the legal status of the product?
Answer: The product is Rx-Only, meaning it is available by prescription only. This ensures that its use is monitored by a healthcare professional, which is essential for managing potential side effects and interactions with other medications.
